Back
Structure Therapeutics Vs. Amgen Industry Stock Comparison
Sell
32
GPCR
Structure Therapeutics
Last Price:
33.44
Seasonality Move:
-14.82%
Sell
38
AMGN
Amgen
Last Price:
294.52
Seasonality Move:
9.62%
Sell
32
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics a Buy, Sell or Hold?
- The current Structure Therapeutics [GPCR] share price is $33.41. The Score for GPCR is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- GPCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Amgen (AMGN)
is a Sell
Is Amgen a Buy, Sell or Hold?
- The current Amgen [AMGN] share price is $294.53. The Score for AMGN is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- AMGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GPCR Stock Price Chart
What is Structure Therapeutics's stock price today?
-
The Structure Therapeutics share price today is $33.41
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.86 | Sell |
| Relative Strength Index (14 RSI): | 41.58 | Sell |
| Chaikin Money Flow: | 882035 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.2 - 39.9) | Sell |
| Bollinger Bands (100): | (35.54 - 41.32) | Sell |
AMGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -8.97 | Sell |
| Relative Strength Index (14 RSI): | 40.27 | Sell |
| Chaikin Money Flow: | 2042722 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (293.73 - 323.09) | Sell |
| Bollinger Bands (100): | (309.75 - 334.27) | Sell |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.62 | Sell |
| 20-day SMA: | 36.75 | Sell |
| 50-day SMA: | 38.81 | Sell |
| 200-day SMA: | 39.76 | Sell |
| 8-day EMA: | 33.58 | Sell |
| 20-day EMA: | 35.75 | Sell |
| 50-day EMA: | 37.61 | Sell |
| 200-day EMA: | 39.17 | Sell |
AMGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 289 | Buy |
| 20-day SMA: | 306.32 | Sell |
| 50-day SMA: | 316.75 | Sell |
| 200-day SMA: | 305.77 | Sell |
| 8-day EMA: | 292.57 | Buy |
| 20-day EMA: | 302.07 | Sell |
| 50-day EMA: | 312.08 | Sell |
| 200-day EMA: | 306.79 | Sell |
Structure Therapeutics Earnings Growth & GPCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.15 per share.
Amgen Earnings Growth & AMGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $1.07 per share.
Structure Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amgen Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||